Search research articles
Contact Us
Filters
Showing results (111-120 of 325) with videos related to
Page
of 33
Sort By:
Leukemia & Lymphoma
|
May 26, 2010
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia
Tait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Molecular Cancer Therapeutics
|
September 21, 2006
Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways
Chunrong Yu, Bret B Friday, Jin-Ping Lai, et al.
Mayo Clinic Proceedings
|
April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test
Grzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Haematologica
|
September 17, 2016
Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia
Paolo Strati, Kari G Chaffee, Sara J Achenbach, et al.
British Journal of Haematology
|
February 18, 2011
Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cells
Xiaosheng Wu, Stephanie A Smoley, Mark A Peterson, et al.
Leukemia Research
|
July 29, 2008
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia
Tait D Shanafelt, Deborah A Bowen, Chaya Venkat, et al.
Iscience
|
January 18, 2021
Chronic lymphocytic leukemia B-cell-derived TNFα impairs bone marrow myelopoiesis
Bryce A Manso, Jordan E Krull, Kimberly A Gwin, et al.
Oncotarget
|
November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
Neil E Kay, Paolo Strati, Betsy R LaPlant, et al.
Leukemia & Lymphoma
|
December 11, 2007
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features
Deborah A Bowen, Timothy G Call, Greg D Jenkins, et al.
British Journal of Haematology
|
November 11, 2014
Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia
Juhi Ojha, Charla R Secreto, Kari G Rabe, et al.
Page
of 33
Search research articles
Search
Showing results (111-120 of 325) with videos related to
Sort By:
Page
of 33
Leukemia & Lymphoma
|
May 26, 2010
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia
Tait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Molecular Cancer Therapeutics
|
September 21, 2006
Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways
Chunrong Yu, Bret B Friday, Jin-Ping Lai, et al.
Mayo Clinic Proceedings
|
April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test
Grzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Haematologica
|
September 17, 2016
Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia
Paolo Strati, Kari G Chaffee, Sara J Achenbach, et al.
British Journal of Haematology
|
February 18, 2011
Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cells
Xiaosheng Wu, Stephanie A Smoley, Mark A Peterson, et al.
Leukemia Research
|
July 29, 2008
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia
Tait D Shanafelt, Deborah A Bowen, Chaya Venkat, et al.
Iscience
|
January 18, 2021
Chronic lymphocytic leukemia B-cell-derived TNFα impairs bone marrow myelopoiesis
Bryce A Manso, Jordan E Krull, Kimberly A Gwin, et al.
Oncotarget
|
November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
Neil E Kay, Paolo Strati, Betsy R LaPlant, et al.
Leukemia & Lymphoma
|
December 11, 2007
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features
Deborah A Bowen, Timothy G Call, Greg D Jenkins, et al.
British Journal of Haematology
|
November 11, 2014
Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia
Juhi Ojha, Charla R Secreto, Kari G Rabe, et al.
Page
of 33